A carregar...
Promising Results from Alzheimer's Disease Passive Immunotherapy Support the Development of a Preventive Vaccine
The apparently near-term effects of the monoclonal antibody BAN2401 in slowing the progression of prodromal Alzheimer's disease (AD) has created cautious optimism about the therapeutic use of antibodies that neutralize cytotoxic soluble amyloid-β aggregates, rather than removing plaque. Plaque...
Na minha lista:
| Publicado no: | Research (Wash D C) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AAAS
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6750119/ https://ncbi.nlm.nih.gov/pubmed/31549066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.34133/2019/5341375 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|